Systemic therapy in cervical cancer: 30 years in review-Reference-Cited by-同舟云学术

Systemic therapy in cervical cancer: 30 years in review

Published:2019-05 Issue: Volume:137 Page:9-17
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Liontos Michalis,Kyriazoglou Anastasios^ORCID,Dimitriadis Ioannis,Dimopoulos Meletios-Athanasios,Bamias Aristotelis^ORCID

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference117 articles.

1. Mitomycin-C, bleomycin, vincristine, and cis-platinum in the treatment of advanced, recurrent squamous cell carcinoma of the cervix;Alberts;Cancer Clin. Trials,1981

2. Neoadjuvant chemotherapy for locally advanced cervical cancer;Anon;Eur. J. Cancer,2003

3. A phase II study of carboplatin in advanced squamous cell carcinoma of the cervix (a gynecologic oncology group study);Arseneau;Invest. New Drugs,1986

4. Synergistic interaction between topotecan and microtubule-interfering agents;Bahadori;Cancer Chemother. Pharmacol.,2001

5. Gynecological cancers in developing countries: the challenge of chemotherapy in low-resources setting;Basile;Int. J. Gynecol. Cancer,2006

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnology-based Drug Delivery Systems for the Treatment of Cervical Cancer: A Comprehensive Review;Current Nanoscience;2024-03

2. Survival outcomes in patients undergoing different treatments for small cell endocrine carcinoma of the cervix: a retrospective analysis;2024-01-05

3. Interplay of miR-542, miR-126, miR-143 and miR-26b withPI3K-AKT is a diagnostic signal and putative regulatory target in HPV-Positive Cervical Cancer;2024-01-05

4. Iron sucrose induced ferroptosis for recruiting and awakening immune cells in the ascite fluid of hepatocellular carcinoma: Preparation for immunotherapy;2024-01-03

5. Chemotherapy alone versus chemotherapy plus 125I brachytherapy for the second-line treatment of locally recurrent cervical cancer after/with radical treatment: A propensity score analysis;Heliyon;2024-01